CC Community News Digest (December 7-13)

Assorted news from the last week:

Nature reports that children with cancer with SARS-CoV-2 infection do not appear at increased risk of severe infection compared to the general paediatric population. This is reassuring and supports the continued delivery of standard treatment.

Covid-19 surge could lead to another drop in patient visits, doctors fear — and more missed pediatric cancers.

Kazia Therapeutics Limited , an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clinical trial of multiple therapies, including Kazia’s investigational new drug, paxalisib (formerly GDC-0084), in diffuse midline gliomas including diffuse intrinsic pontine glioma (DIPG).

Upcoming Webinars and Online Opportunities:

The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions webinar on Thursday, December 17 10:00ET. Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please register to hearing about the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.

Five episodes of The Promise a docuseries about childhood cancer appeared on YouTube Live this week and are now available for on demand viewing.  This production features a number of CAC2 Members:  Donna Carmical (Journey4ACure), Ellyn Miller (Smashing Walnuts), Janet Demeter (Jack’s Angels), Joe Baber, Peter & Vicki Brown (Mattie Miracle), and Ricardo Garcia (Richi Foundation).

In this episode of A Cancer Survivor’s Guide to Chemo, Dr. Diane Reidy-Lagunes speaks with Elizabeth Cruz, a registered nurse at MSK, and Stacey Peltz, an eight-year cancer survivor and warrior. Together, they’ll run down what you need to know to prepare for treatment and how to live well on chemotherapy.

Enquire now

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.